Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001072613-26-000468
Filing Date
2026-05-18
Accepted
2026-05-18 18:29:41
Documents
3
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 36085
2 AGREEMENT REGARDING FILING OF JOINT SCHEDULE 13D exh1.htm EX-1 44796
3 - POWER OF ATTORNEY REGARDING FILINGS UNDER THE SECURITIES EXCHANGE ACT OF 1934, exh2.htm EX-2 92171
  Complete submission text file 0001072613-26-000468.txt   174737
Mailing Address 929 MAIN STREET SUITE 200 REDWOOD CITY CA 94063
Business Address 929 MAIN STREET SUITE 200 REDWOOD CITY CA 94063 (410) 800-7503
SR ONE CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001853723 (see all company filings)

EIN.: 843383413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D

Mailing Address 51 SLEEPER STREET BOSTON MA 02210
Business Address 51 SLEEPER STREET BOSTON MA 02210 (212) 841-1000
Odyssey Therapeutics, Inc. (Subject) CIK: 0001882782 (see all company filings)

EIN.: 863384382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-95704 | Film No.: 26995355
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)